> top > projects > spacy-test > docs > PubMed:3923949 > annotations
spacy-test Home  

PubMed:3923949 JSONTXT 2 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
spaCy_T0 0-4 NNP denotes High
spaCy_T1 5-10 NNS denotes doses
spaCy_T2 11-13 IN denotes of
spaCy_T3 14-33 JJ denotes antigen-nonspecific
spaCy_T4 34-37 NNP denotes IgG
spaCy_T5 38-40 VBP denotes do
spaCy_T6 41-44 RB denotes not
spaCy_T7 45-52 VB denotes inhibit
spaCy_T8 53-62 NN denotes pemphigus
spaCy_T9 63-75 NN denotes acantholysis
spaCy_T10 76-78 IN denotes in
spaCy_T11 79-83 NN denotes skin
spaCy_T12 84-89 NN denotes organ
spaCy_T13 90-98 NNS denotes cultures
spaCy_T14 98-99 . denotes .
spaCy_T15 100-101 DT denotes A
spaCy_T16 102-109 JJ denotes patient
spaCy_T17 110-119 NN denotes suffering
spaCy_T18 120-124 IN denotes from
spaCy_T19 125-131 JJ denotes severe
spaCy_T20 132-141 NN denotes pemphigus
spaCy_T21 142-150 NN denotes vulgaris
spaCy_T22 151-154 VBD denotes was
spaCy_T23 155-162 VBN denotes treated
spaCy_T24 163-168 VBG denotes using
spaCy_T25 169-181 JJ denotes large-volume
spaCy_T26 182-188 NN denotes plasma
spaCy_T27 189-197 NN denotes exchange
spaCy_T28 198-200 IN denotes in
spaCy_T29 201-212 NN denotes combination
spaCy_T30 213-217 IN denotes with
spaCy_T31 218-220 DT denotes an
spaCy_T32 221-238 JJ denotes immunosuppressive
spaCy_T33 239-246 NN denotes regimen
spaCy_T34 246-247 . denotes .
spaCy_T35 248-250 IN denotes As
spaCy_T36 251-255 DT denotes some
spaCy_T37 256-262 JJ denotes recent
spaCy_T38 263-270 NNS denotes reports
spaCy_T39 271-275 VBP denotes have
spaCy_T40 276-281 VBN denotes shown
spaCy_T41 282-290 NN denotes evidence
spaCy_T42 291-295 IN denotes that
spaCy_T43 296-306 JJ denotes polyclonal
spaCy_T44 306-307 , denotes ,
spaCy_T45 308-320 JJ denotes polyspecific
spaCy_T46 321-326 JJ denotes human
spaCy_T47 327-330 NNP denotes IgG
spaCy_T48 331-333 IN denotes in
spaCy_T49 334-338 JJ denotes high
spaCy_T50 339-344 NNS denotes doses
spaCy_T51 345-352 IN denotes through
spaCy_T52 353-356 DT denotes the
spaCy_T53 357-361 JJ denotes i.v.
spaCy_T54 362-367 NN denotes route
spaCy_T55 368-369 -LRB- denotes (
spaCy_T56 369-373 NNP denotes IGIV
spaCy_T57 373-374 -RRB- denotes )
spaCy_T58 375-382 VBP denotes protect
spaCy_T59 383-389 NN denotes target
spaCy_T60 390-399 NNS denotes platelets
spaCy_T61 400-402 IN denotes in
spaCy_T62 403-413 JJ denotes idiopathic
spaCy_T63 414-430 JJ denotes thrombocytopenic
spaCy_T64 431-438 NN denotes purpura
spaCy_T65 439-443 IN denotes from
spaCy_T66 444-450 NN denotes attack
spaCy_T67 451-453 IN denotes by
spaCy_T68 454-466 JJ denotes antiplatelet
spaCy_T69 467-481 NNS denotes autoantibodies
spaCy_T70 482-488 CC denotes and/or
spaCy_T71 489-495 JJ denotes immune
spaCy_T72 496-505 NNS denotes complexes
spaCy_T73 505-506 , denotes ,
spaCy_T74 507-509 PRP denotes we
spaCy_T75 510-514 RB denotes also
spaCy_T76 515-527 VBD denotes administered
spaCy_T77 528-532 NNP denotes IGIV
spaCy_T78 533-535 TO denotes to
spaCy_T79 536-540 DT denotes this
spaCy_T80 541-559 JJ denotes pemphigus-vulgaris
spaCy_T81 560-567 NN denotes patient
spaCy_T82 567-568 . denotes .
spaCy_T83 569-571 IN denotes In
spaCy_T84 572-577 NN denotes order
spaCy_T85 578-580 TO denotes to
spaCy_T86 581-585 VB denotes test
spaCy_T87 586-589 DT denotes the
spaCy_T88 590-600 NN denotes hypothesis
spaCy_T89 601-605 WDT denotes that
spaCy_T90 606-610 NNP denotes IGIV
spaCy_T91 611-616 MD denotes might
spaCy_T92 617-624 VB denotes protect
spaCy_T93 625-627 IN denotes in
spaCy_T94 628-642 JJ denotes vitro-cultured
spaCy_T95 643-648 JJ denotes human
spaCy_T96 649-653 NN denotes skin
spaCy_T97 654-658 IN denotes from
spaCy_T98 659-671 NN denotes acantholysis
spaCy_T99 672-679 VBN denotes induced
spaCy_T100 680-682 IN denotes by
spaCy_T101 683-692 NN denotes pemphigus
spaCy_T102 693-703 NNS denotes antibodies
spaCy_T103 703-704 , denotes ,
spaCy_T104 705-712 NNS denotes studies
spaCy_T105 713-717 IN denotes with
spaCy_T106 718-722 NN denotes skin
spaCy_T107 723-728 NN denotes organ
spaCy_T108 729-737 NNS denotes cultures
spaCy_T109 738-742 VBD denotes were
spaCy_T110 743-750 VBN denotes carried
spaCy_T111 751-754 IN denotes out
spaCy_T112 755-760 VBG denotes using
spaCy_T113 761-767 NN denotes plasma
spaCy_T114 768-772 IN denotes from
spaCy_T115 773-780 DT denotes another
spaCy_T116 781-799 JJ denotes pemphigus-vulgaris
spaCy_T117 800-807 NN denotes patient
spaCy_T118 808-811 WP denotes who
spaCy_T119 812-815 VBD denotes had
spaCy_T120 816-825 VBN denotes undergone
spaCy_T121 826-832 NN denotes plasma
spaCy_T122 833-841 NN denotes exchange
spaCy_T123 841-842 . denotes .
spaCy_T124 843-846 DT denotes The
spaCy_T125 847-860 NN denotes preincubation
spaCy_T126 861-863 IN denotes of
spaCy_T127 864-870 CC denotes either
spaCy_T128 871-874 DT denotes the
spaCy_T129 875-879 NN denotes skin
spaCy_T130 880-888 VBZ denotes explants
spaCy_T131 889-891 CC denotes or
spaCy_T132 892-895 DT denotes the
spaCy_T133 896-905 NN denotes pemphigus
spaCy_T134 906-912 NN denotes plasma
spaCy_T135 913-917 IN denotes with
spaCy_T136 918-925 JJ denotes various
spaCy_T137 926-940 NNS denotes concentrations
spaCy_T138 941-943 IN denotes of
spaCy_T139 944-948 NNP denotes IGIV
spaCy_T140 949-950 -LRB- denotes (
spaCy_T141 950-957 VBG denotes ranging
spaCy_T142 958-962 IN denotes from
spaCy_T143 963-967 CD denotes 0.15
spaCy_T144 968-970 TO denotes to
spaCy_T145 971-973 CD denotes 15
spaCy_T146 974-979 NN denotes mg/ml
spaCy_T147 980-982 IN denotes in
spaCy_T148 983-986 DT denotes the
spaCy_T149 987-994 NN denotes culture
spaCy_T150 995-1001 NN denotes medium
spaCy_T151 1001-1002 -RRB- denotes )
spaCy_T152 1003-1006 VBD denotes did
spaCy_T153 1007-1010 RB denotes not
spaCy_T154 1011-1018 VB denotes prevent
spaCy_T155 1019-1031 NN denotes acantholysis
spaCy_T156 1032-1039 VBN denotes induced
spaCy_T157 1040-1042 IN denotes by
spaCy_T158 1043-1046 DT denotes the
spaCy_T159 1047-1056 NN denotes pemphigus
spaCy_T160 1057-1063 NN denotes plasma
spaCy_T161 1064-1067 CC denotes nor
spaCy_T162 1068-1071 VBD denotes did
spaCy_T163 1072-1074 PRP denotes it
spaCy_T164 1075-1082 VB denotes inhibit
spaCy_T165 1083-1086 DT denotes the
spaCy_T166 1087-1094 JJ denotes binding
spaCy_T167 1095-1097 IN denotes of
spaCy_T168 1098-1101 DT denotes the
spaCy_T169 1102-1110 JJ denotes specific
spaCy_T170 1111-1121 NNS denotes antibodies
spaCy_T171 1122-1132 VBN denotes visualized
spaCy_T172 1133-1135 IN denotes by
spaCy_T173 1136-1142 JJ denotes direct
spaCy_T174 1143-1161 NN denotes immunofluorescence
spaCy_T175 1161-1162 . denotes .
spaCy_T176 1163-1167 RB denotes Thus
spaCy_T177 1167-1168 , denotes ,
spaCy_T178 1169-1172 DT denotes the
spaCy_T179 1173-1183 NN denotes assumption
spaCy_T180 1184-1188 IN denotes that
spaCy_T181 1189-1193 NNP denotes IGIV
spaCy_T182 1194-1197 MD denotes may
spaCy_T183 1198-1202 NN denotes coat
spaCy_T184 1203-1206 DT denotes the
spaCy_T185 1207-1216 NN denotes pemphigus
spaCy_T186 1217-1225 NNS denotes antigens
spaCy_T187 1226-1228 IN denotes on
spaCy_T188 1229-1238 JJ denotes epidermal
spaCy_T189 1239-1244 NNS denotes cells
spaCy_T190 1245-1251 VBG denotes making
spaCy_T191 1252-1256 PRP denotes them
spaCy_T192 1257-1269 JJ denotes inaccessible
spaCy_T193 1270-1272 TO denotes to
spaCy_T194 1273-1283 JJ denotes pathogenic
spaCy_T195 1284-1298 NNS denotes autoantibodies
spaCy_T196 1299-1302 VBD denotes was
spaCy_T197 1303-1306 RB denotes not
spaCy_T198 1307-1320 VBN denotes substantiated
spaCy_T199 1321-1323 IN denotes by
spaCy_T200 1324-1327 PRP$ denotes our
spaCy_T201 1328-1333 NNS denotes tests
spaCy_T202 1334-1336 IN denotes in
spaCy_T203 1337-1342 NN denotes vitro
spaCy_T204 1342-1343 : denotes ;
spaCy_T205 1344-1352 RB denotes likewise
spaCy_T206 1352-1353 , denotes ,
spaCy_T207 1354-1357 DT denotes the
spaCy_T208 1358-1368 NN denotes hypothesis
spaCy_T209 1369-1371 IN denotes of
spaCy_T210 1372-1384 RB denotes functionally
spaCy_T211 1385-1393 VBG denotes blocking
spaCy_T212 1394-1406 JJ denotes autoantibody
spaCy_T213 1407-1415 NN denotes activity
spaCy_T214 1416-1418 IN denotes by
spaCy_T215 1419-1424 NNS denotes means
spaCy_T216 1425-1427 IN denotes of
spaCy_T217 1428-1441 JJ denotes anti-idiotype
spaCy_T218 1442-1449 NNS denotes effects
spaCy_T219 1450-1452 IN denotes of
spaCy_T220 1453-1457 NNP denotes IGIV
spaCy_T221 1458-1461 MD denotes can
spaCy_T222 1461-1464 RB denotes not
spaCy_T223 1465-1467 VB denotes be
spaCy_T224 1468-1477 VBN denotes supported
spaCy_T225 1477-1478 . denotes .
spaCy_R0 spaCy_T0 spaCy_T1 amod High,doses
spaCy_R1 spaCy_T1 spaCy_T7 nsubj doses,inhibit
spaCy_R10 spaCy_T10 spaCy_T9 prep in,acantholysis
spaCy_R100 spaCy_T100 spaCy_T99 agent by,induced
spaCy_R101 spaCy_T101 spaCy_T102 compound pemphigus,antibodies
spaCy_R102 spaCy_T102 spaCy_T100 pobj antibodies,by
spaCy_R103 spaCy_T103 spaCy_T102 punct ",",antibodies
spaCy_R104 spaCy_T104 spaCy_T102 appos studies,antibodies
spaCy_R105 spaCy_T105 spaCy_T104 prep with,studies
spaCy_R106 spaCy_T106 spaCy_T108 compound skin,cultures
spaCy_R107 spaCy_T107 spaCy_T108 compound organ,cultures
spaCy_R108 spaCy_T108 spaCy_T105 pobj cultures,with
spaCy_R109 spaCy_T109 spaCy_T110 auxpass were,carried
spaCy_R11 spaCy_T11 spaCy_T13 compound skin,cultures
spaCy_R110 spaCy_T110 spaCy_T110 ROOT carried,carried
spaCy_R111 spaCy_T111 spaCy_T110 prt out,carried
spaCy_R112 spaCy_T112 spaCy_T110 advcl using,carried
spaCy_R113 spaCy_T113 spaCy_T112 dobj plasma,using
spaCy_R114 spaCy_T114 spaCy_T112 prep from,using
spaCy_R115 spaCy_T115 spaCy_T117 det another,patient
spaCy_R116 spaCy_T116 spaCy_T117 amod pemphigus-vulgaris,patient
spaCy_R117 spaCy_T117 spaCy_T114 pobj patient,from
spaCy_R118 spaCy_T118 spaCy_T120 nsubj who,undergone
spaCy_R119 spaCy_T119 spaCy_T120 aux had,undergone
spaCy_R12 spaCy_T12 spaCy_T13 compound organ,cultures
spaCy_R120 spaCy_T120 spaCy_T117 relcl undergone,patient
spaCy_R121 spaCy_T121 spaCy_T122 compound plasma,exchange
spaCy_R122 spaCy_T122 spaCy_T120 dobj exchange,undergone
spaCy_R123 spaCy_T123 spaCy_T110 punct .,carried
spaCy_R124 spaCy_T124 spaCy_T125 det The,preincubation
spaCy_R125 spaCy_T125 spaCy_T154 nsubj preincubation,prevent
spaCy_R126 spaCy_T126 spaCy_T125 prep of,preincubation
spaCy_R127 spaCy_T127 spaCy_T130 preconj either,explants
spaCy_R128 spaCy_T128 spaCy_T129 det the,skin
spaCy_R129 spaCy_T129 spaCy_T130 nsubj skin,explants
spaCy_R13 spaCy_T13 spaCy_T10 pobj cultures,in
spaCy_R130 spaCy_T130 spaCy_T126 pobj explants,of
spaCy_R131 spaCy_T131 spaCy_T130 cc or,explants
spaCy_R132 spaCy_T132 spaCy_T134 det the,plasma
spaCy_R133 spaCy_T133 spaCy_T134 compound pemphigus,plasma
spaCy_R134 spaCy_T134 spaCy_T130 conj plasma,explants
spaCy_R135 spaCy_T135 spaCy_T134 prep with,plasma
spaCy_R136 spaCy_T136 spaCy_T137 amod various,concentrations
spaCy_R137 spaCy_T137 spaCy_T135 pobj concentrations,with
spaCy_R138 spaCy_T138 spaCy_T137 prep of,concentrations
spaCy_R139 spaCy_T139 spaCy_T138 pobj IGIV,of
spaCy_R14 spaCy_T14 spaCy_T7 punct .,inhibit
spaCy_R140 spaCy_T140 spaCy_T139 punct (,IGIV
spaCy_R141 spaCy_T141 spaCy_T139 acl ranging,IGIV
spaCy_R142 spaCy_T142 spaCy_T141 prep from,ranging
spaCy_R143 spaCy_T143 spaCy_T142 pobj 0.15,from
spaCy_R144 spaCy_T144 spaCy_T142 prep to,from
spaCy_R145 spaCy_T145 spaCy_T146 nummod 15,mg/ml
spaCy_R146 spaCy_T146 spaCy_T144 pobj mg/ml,to
spaCy_R147 spaCy_T147 spaCy_T146 prep in,mg/ml
spaCy_R148 spaCy_T148 spaCy_T150 det the,medium
spaCy_R149 spaCy_T149 spaCy_T150 compound culture,medium
spaCy_R15 spaCy_T15 spaCy_T17 det A,suffering
spaCy_R150 spaCy_T150 spaCy_T147 pobj medium,in
spaCy_R151 spaCy_T151 spaCy_T139 punct ),IGIV
spaCy_R152 spaCy_T152 spaCy_T154 aux did,prevent
spaCy_R153 spaCy_T153 spaCy_T154 neg not,prevent
spaCy_R154 spaCy_T154 spaCy_T154 ROOT prevent,prevent
spaCy_R155 spaCy_T155 spaCy_T154 dobj acantholysis,prevent
spaCy_R156 spaCy_T156 spaCy_T155 acl induced,acantholysis
spaCy_R157 spaCy_T157 spaCy_T156 agent by,induced
spaCy_R158 spaCy_T158 spaCy_T160 det the,plasma
spaCy_R159 spaCy_T159 spaCy_T160 amod pemphigus,plasma
spaCy_R16 spaCy_T16 spaCy_T17 nsubj patient,suffering
spaCy_R160 spaCy_T160 spaCy_T157 pobj plasma,by
spaCy_R161 spaCy_T161 spaCy_T154 cc nor,prevent
spaCy_R162 spaCy_T162 spaCy_T164 aux did,inhibit
spaCy_R163 spaCy_T163 spaCy_T164 nsubj it,inhibit
spaCy_R164 spaCy_T164 spaCy_T154 conj inhibit,prevent
spaCy_R165 spaCy_T165 spaCy_T166 det the,binding
spaCy_R166 spaCy_T166 spaCy_T164 dobj binding,inhibit
spaCy_R167 spaCy_T167 spaCy_T166 prep of,binding
spaCy_R168 spaCy_T168 spaCy_T170 det the,antibodies
spaCy_R169 spaCy_T169 spaCy_T170 amod specific,antibodies
spaCy_R17 spaCy_T17 spaCy_T23 nsubjpass suffering,treated
spaCy_R170 spaCy_T170 spaCy_T167 pobj antibodies,of
spaCy_R171 spaCy_T171 spaCy_T170 acl visualized,antibodies
spaCy_R172 spaCy_T172 spaCy_T171 agent by,visualized
spaCy_R173 spaCy_T173 spaCy_T174 amod direct,immunofluorescence
spaCy_R174 spaCy_T174 spaCy_T172 pobj immunofluorescence,by
spaCy_R175 spaCy_T175 spaCy_T164 punct .,inhibit
spaCy_R176 spaCy_T176 spaCy_T198 advmod Thus,substantiated
spaCy_R177 spaCy_T177 spaCy_T198 punct ",",substantiated
spaCy_R178 spaCy_T178 spaCy_T179 det the,assumption
spaCy_R179 spaCy_T179 spaCy_T198 nsubjpass assumption,substantiated
spaCy_R18 spaCy_T18 spaCy_T17 prep from,suffering
spaCy_R180 spaCy_T180 spaCy_T183 mark that,coat
spaCy_R181 spaCy_T181 spaCy_T183 nsubj IGIV,coat
spaCy_R182 spaCy_T182 spaCy_T183 aux may,coat
spaCy_R183 spaCy_T183 spaCy_T198 nsubjpass coat,substantiated
spaCy_R184 spaCy_T184 spaCy_T186 det the,antigens
spaCy_R185 spaCy_T185 spaCy_T186 compound pemphigus,antigens
spaCy_R186 spaCy_T186 spaCy_T183 dobj antigens,coat
spaCy_R187 spaCy_T187 spaCy_T186 prep on,antigens
spaCy_R188 spaCy_T188 spaCy_T189 amod epidermal,cells
spaCy_R189 spaCy_T189 spaCy_T187 pobj cells,on
spaCy_R19 spaCy_T19 spaCy_T21 amod severe,vulgaris
spaCy_R190 spaCy_T190 spaCy_T183 advcl making,coat
spaCy_R191 spaCy_T191 spaCy_T192 nsubj them,inaccessible
spaCy_R192 spaCy_T192 spaCy_T190 ccomp inaccessible,making
spaCy_R193 spaCy_T193 spaCy_T192 prep to,inaccessible
spaCy_R194 spaCy_T194 spaCy_T195 amod pathogenic,autoantibodies
spaCy_R195 spaCy_T195 spaCy_T193 pobj autoantibodies,to
spaCy_R196 spaCy_T196 spaCy_T198 auxpass was,substantiated
spaCy_R197 spaCy_T197 spaCy_T198 neg not,substantiated
spaCy_R198 spaCy_T198 spaCy_T224 ccomp substantiated,supported
spaCy_R199 spaCy_T199 spaCy_T198 agent by,substantiated
spaCy_R2 spaCy_T2 spaCy_T1 prep of,doses
spaCy_R20 spaCy_T20 spaCy_T21 compound pemphigus,vulgaris
spaCy_R200 spaCy_T200 spaCy_T201 poss our,tests
spaCy_R201 spaCy_T201 spaCy_T199 pobj tests,by
spaCy_R202 spaCy_T202 spaCy_T198 prep in,substantiated
spaCy_R203 spaCy_T203 spaCy_T202 pobj vitro,in
spaCy_R204 spaCy_T204 spaCy_T224 punct ;,supported
spaCy_R205 spaCy_T205 spaCy_T224 advmod likewise,supported
spaCy_R206 spaCy_T206 spaCy_T224 punct ",",supported
spaCy_R207 spaCy_T207 spaCy_T208 det the,hypothesis
spaCy_R208 spaCy_T208 spaCy_T224 nsubjpass hypothesis,supported
spaCy_R209 spaCy_T209 spaCy_T208 prep of,hypothesis
spaCy_R21 spaCy_T21 spaCy_T18 pobj vulgaris,from
spaCy_R210 spaCy_T210 spaCy_T211 advmod functionally,blocking
spaCy_R211 spaCy_T211 spaCy_T209 pcomp blocking,of
spaCy_R212 spaCy_T212 spaCy_T213 amod autoantibody,activity
spaCy_R213 spaCy_T213 spaCy_T211 dobj activity,blocking
spaCy_R214 spaCy_T214 spaCy_T211 prep by,blocking
spaCy_R215 spaCy_T215 spaCy_T214 pobj means,by
spaCy_R216 spaCy_T216 spaCy_T215 prep of,means
spaCy_R217 spaCy_T217 spaCy_T218 amod anti-idiotype,effects
spaCy_R218 spaCy_T218 spaCy_T216 pobj effects,of
spaCy_R219 spaCy_T219 spaCy_T218 prep of,effects
spaCy_R22 spaCy_T22 spaCy_T23 auxpass was,treated
spaCy_R220 spaCy_T220 spaCy_T219 pobj IGIV,of
spaCy_R221 spaCy_T221 spaCy_T224 aux can,supported
spaCy_R222 spaCy_T222 spaCy_T224 neg not,supported
spaCy_R223 spaCy_T223 spaCy_T224 auxpass be,supported
spaCy_R224 spaCy_T224 spaCy_T224 ROOT supported,supported
spaCy_R225 spaCy_T225 spaCy_T224 punct .,supported
spaCy_R23 spaCy_T23 spaCy_T23 ROOT treated,treated
spaCy_R24 spaCy_T24 spaCy_T23 advcl using,treated
spaCy_R25 spaCy_T25 spaCy_T27 amod large-volume,exchange
spaCy_R26 spaCy_T26 spaCy_T27 compound plasma,exchange
spaCy_R27 spaCy_T27 spaCy_T24 dobj exchange,using
spaCy_R28 spaCy_T28 spaCy_T24 prep in,using
spaCy_R29 spaCy_T29 spaCy_T28 pobj combination,in
spaCy_R3 spaCy_T3 spaCy_T4 compound antigen-nonspecific,IgG
spaCy_R30 spaCy_T30 spaCy_T24 prep with,using
spaCy_R31 spaCy_T31 spaCy_T33 det an,regimen
spaCy_R32 spaCy_T32 spaCy_T33 amod immunosuppressive,regimen
spaCy_R33 spaCy_T33 spaCy_T30 pobj regimen,with
spaCy_R34 spaCy_T34 spaCy_T23 punct .,treated
spaCy_R35 spaCy_T35 spaCy_T40 mark As,shown
spaCy_R36 spaCy_T36 spaCy_T38 det some,reports
spaCy_R37 spaCy_T37 spaCy_T38 amod recent,reports
spaCy_R38 spaCy_T38 spaCy_T40 nsubj reports,shown
spaCy_R39 spaCy_T39 spaCy_T40 aux have,shown
spaCy_R4 spaCy_T4 spaCy_T2 pobj IgG,of
spaCy_R40 spaCy_T40 spaCy_T76 advcl shown,administered
spaCy_R41 spaCy_T41 spaCy_T40 dobj evidence,shown
spaCy_R42 spaCy_T42 spaCy_T58 mark that,protect
spaCy_R43 spaCy_T43 spaCy_T47 amod polyclonal,IgG
spaCy_R44 spaCy_T44 spaCy_T47 punct ",",IgG
spaCy_R45 spaCy_T45 spaCy_T47 amod polyspecific,IgG
spaCy_R46 spaCy_T46 spaCy_T47 amod human,IgG
spaCy_R47 spaCy_T47 spaCy_T58 nsubj IgG,protect
spaCy_R48 spaCy_T48 spaCy_T47 prep in,IgG
spaCy_R49 spaCy_T49 spaCy_T50 amod high,doses
spaCy_R5 spaCy_T5 spaCy_T7 aux do,inhibit
spaCy_R50 spaCy_T50 spaCy_T48 pobj doses,in
spaCy_R51 spaCy_T51 spaCy_T47 prep through,IgG
spaCy_R52 spaCy_T52 spaCy_T54 det the,route
spaCy_R53 spaCy_T53 spaCy_T54 compound i.v.,route
spaCy_R54 spaCy_T54 spaCy_T51 pobj route,through
spaCy_R55 spaCy_T55 spaCy_T54 punct (,route
spaCy_R56 spaCy_T56 spaCy_T54 appos IGIV,route
spaCy_R57 spaCy_T57 spaCy_T54 punct ),route
spaCy_R58 spaCy_T58 spaCy_T41 acl protect,evidence
spaCy_R59 spaCy_T59 spaCy_T60 compound target,platelets
spaCy_R6 spaCy_T6 spaCy_T7 neg not,inhibit
spaCy_R60 spaCy_T60 spaCy_T58 dobj platelets,protect
spaCy_R61 spaCy_T61 spaCy_T60 prep in,platelets
spaCy_R62 spaCy_T62 spaCy_T64 amod idiopathic,purpura
spaCy_R63 spaCy_T63 spaCy_T64 amod thrombocytopenic,purpura
spaCy_R64 spaCy_T64 spaCy_T61 pobj purpura,in
spaCy_R65 spaCy_T65 spaCy_T64 prep from,purpura
spaCy_R66 spaCy_T66 spaCy_T65 pobj attack,from
spaCy_R67 spaCy_T67 spaCy_T66 prep by,attack
spaCy_R68 spaCy_T68 spaCy_T69 amod antiplatelet,autoantibodies
spaCy_R69 spaCy_T69 spaCy_T67 pobj autoantibodies,by
spaCy_R7 spaCy_T7 spaCy_T7 ROOT inhibit,inhibit
spaCy_R70 spaCy_T70 spaCy_T69 cc and/or,autoantibodies
spaCy_R71 spaCy_T71 spaCy_T72 amod immune,complexes
spaCy_R72 spaCy_T72 spaCy_T69 conj complexes,autoantibodies
spaCy_R73 spaCy_T73 spaCy_T76 punct ",",administered
spaCy_R74 spaCy_T74 spaCy_T76 nsubj we,administered
spaCy_R75 spaCy_T75 spaCy_T76 advmod also,administered
spaCy_R76 spaCy_T76 spaCy_T76 ROOT administered,administered
spaCy_R77 spaCy_T77 spaCy_T76 dobj IGIV,administered
spaCy_R78 spaCy_T78 spaCy_T76 prep to,administered
spaCy_R79 spaCy_T79 spaCy_T81 det this,patient
spaCy_R8 spaCy_T8 spaCy_T9 compound pemphigus,acantholysis
spaCy_R80 spaCy_T80 spaCy_T81 amod pemphigus-vulgaris,patient
spaCy_R81 spaCy_T81 spaCy_T78 pobj patient,to
spaCy_R82 spaCy_T82 spaCy_T76 punct .,administered
spaCy_R83 spaCy_T83 spaCy_T110 prep In,carried
spaCy_R84 spaCy_T84 spaCy_T83 pobj order,In
spaCy_R85 spaCy_T85 spaCy_T86 aux to,test
spaCy_R86 spaCy_T86 spaCy_T84 acl test,order
spaCy_R87 spaCy_T87 spaCy_T88 det the,hypothesis
spaCy_R88 spaCy_T88 spaCy_T86 dobj hypothesis,test
spaCy_R89 spaCy_T89 spaCy_T92 dobj that,protect
spaCy_R9 spaCy_T9 spaCy_T7 dobj acantholysis,inhibit
spaCy_R90 spaCy_T90 spaCy_T92 nsubj IGIV,protect
spaCy_R91 spaCy_T91 spaCy_T92 aux might,protect
spaCy_R92 spaCy_T92 spaCy_T88 relcl protect,hypothesis
spaCy_R93 spaCy_T93 spaCy_T92 prep in,protect
spaCy_R94 spaCy_T94 spaCy_T96 amod vitro-cultured,skin
spaCy_R95 spaCy_T95 spaCy_T96 amod human,skin
spaCy_R96 spaCy_T96 spaCy_T93 pobj skin,in
spaCy_R97 spaCy_T97 spaCy_T96 prep from,skin
spaCy_R98 spaCy_T98 spaCy_T97 pobj acantholysis,from
spaCy_R99 spaCy_T99 spaCy_T96 acl induced,skin